-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CaA6Rw9QZ8CPi5GSdfwPt+qLySvb6JIGAIh2XwNw2Jt4+CUTSusW7DAgMoLp4AsM puZxmhJySMx5yIAQckXy0A== 0000950103-08-001995.txt : 20080731 0000950103-08-001995.hdr.sgml : 20080731 20080731091720 ACCESSION NUMBER: 0000950103-08-001995 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20080730 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080731 DATE AS OF CHANGE: 20080731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire Ltd. CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 08980631 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: - BUSINESS PHONE: 1264333455 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: - FORMER COMPANY: FORMER CONFORMED NAME: Shire plc DATE OF NAME CHANGE: 20051125 FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp10820_8k.htm
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): July 30, 2008

Shire Limited
________________________________________________________________________________
(Exact name of registrant as specified in its charter)

Jersey
________________________________________________________________________________
(State or other jurisdiction of incorporation)

0-29630                                                  98-0484822
(Commission File Number)                (IRS Employer Identification No.)

Hampshire International Business Park, Chineham, Basingstoke,
Hampshire RG24 8EP England
________________________________________________________________________________
(Address of principal executive offices)                              (Zip code)

Registrant's telephone number, including area code               44 1256 894 000


________________________________________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.f13e-4(c))
 

 
 
 


 
Item 8.01.  Other Events

     Shire Limited has issued the press releases attached hereto as Exhibit 99.01 and 99.02 which are incorporated by reference herein.

Item 9.01.  Financial Statements and Exhibits

                  (d)  Exhibits.  The following exhibits are filed herewith:

99.01                 Press Release dated July 30, 2008
99.02                 Press Release dated July 30, 2008

 
 
 
 

 

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant  has duly caused  this report to be signed on its behalf by the undersigned hereunto duly authorized.


SHIRE LIMITED
 
  
By:
/s/ A C Russell
  
 Name: Angus Russell
  
 Title: Chief Executive Officer
  


Dated: July 30, 2008
 
 
 
 
 
 

 
EXHIBIT INDEX
 
Number
Description
 
99.01
Press Release dated July 30, 2008
99.02
Press Release dated July 30, 2008
 
 
 EX-99.1 2 dp10820_ex9901.htm
 
EXHIBIT 99.01
 
Hampshire International Business Park
Chineham  Basingstoke
Hampshire RG24 8EP
United Kingdom
Tel +44 (0)1256 894000
Fax +44 (0)1256 894708
www.shire.com
   
Press Release
  
 
 
Notification of major interests in shares

Basingstoke, UK and Philadelphia, US – July 30, 2008 – Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Shire Limited

2. Reason for the notification
State
Yes/No
An acquisition or disposal of voting rights
  
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
Yes
An event changing the breakdown of voting rights
  
Other (please specify):  New Exemption DTR 5.1.3 (4) & DTR 5.1.5 (1)
  

3. Full name of person(s) subject to the notification obligation:
ExcellerateHRO Share Plan Services (Guernsey) Limited
4. Full name of shareholder(s) (if different from 3.):
  
5. Date of the transaction (and date on which the threshold is crossed
or reached if different):
13 May 2008
6. Date on which issuer notified:
30 July 2008
7. Threshold(s) that is/are crossed or reached:
3%
8. Notified details:
  

A: Voting rights attached to shares

Class/type of shares
 if possible using the ISIN CODE
Situation previous to
the Triggering
transaction
Resulting situation after the triggering
transaction
 
Number
of
Shares
Number
of
Voting
Rights
Number
of
shares
Number of voting
rights
% of voting
rights
     
Direct
Direct
Indirect
Direct
Indirect
JE00B2QKY057
ADRs
Below 3%
Below 3%
  
8,524,960
2,791,605
8,524,960
8,374,815
  
1.52%
1.50%
  


Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 
 
 
B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument
Expiration
date
Exercise/Conversion
Period/ Date
Number of voting
rights that may be
acquired if  the instrument
is exercised/converted
% of voting
rights
         


Total (A+B)
  
Number of voting rights
% of voting rights
16,899,775
3.02%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
 
 
 
ExcellerateHRO act as trustees of the Shire Employee Benefit Trust and the holdings when the threshold was exceeded was as follows: 
 
Shares Held By
 
 
Registered in the name of
No of consolidated Shares Held
Statestreet Nominees Ltd
ExcellerateHRO SPS (Gsy) Ltd
1,917,710
Equiniti Registrars
ExcellerateHRO SPS (Gsy) Ltd
39,250
Morgan Stanley
ExcellerateHRO SPS (Gsy) Ltd
6,568,000
Morgan Stanley
ExcellerateHRO SPS (Gsy) Ltd
3,910,500
JP Morgan
ExcellerateHRO SPS (Gsy) Ltd
4,464,315
     
Total Shares held by ExcellerateHRO Guernsey Ltd as at 13th May 2008 16.899,775
 
Proxy Voting:

10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A

13. Additional information:
  
14. Contact name:
Emma Holland
15. Contact telephone number:
01481 726088

Contact at Shire Limited: Tony Guthrie, Deputy Company Secretary, 01256 894746
 

For further information please contact:

Investor Relations
Cléa Rosenfeld (Rest of the World)
+44 1256 894 160
 
Eric Rojas (North America)
+1 484 595 8252

Notes to editors

SHIRE LIMITED

Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions.  Shire’s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.  Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company’s website: www.shire.com.

 GRAPHIC 3 shire_logo.jpg GRAPHIC begin 644 shire_logo.jpg M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(" M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@," M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$! M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,` M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I M*C0U-CH.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1 M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`#T`KP,!$0`"$0$#$0'_V@`, M`P$``A$#$0`_`/WYW&@`W&@`W&@`W&@`W8XX'Z8S_*@#ROQ#\T\1 M_%3X?Z)=Q;A)97WBW1(;R(J2&$EH+TS(001@H*]"AE&:5TG0R[$5(]'&C4Y? MD^6WXF4JM&&CJ1CY/.['G"I$Q..!6LZT[PIXSOK%,DY9KRU\/O$$&"2V[&!G.*]"/"'$"BO M]@]GVC*M0C+_`,!=1,R^N89:<^W:,K?@CZ!\#?$SP!\2O#T?BKP%XNT+Q/X> M>9K;^T]+O8WA@NEP7M+R-RDMC>`,I,%Q'%(!(IVX8$^+B\OQF7UGA<7AJF%K M15^246FUWC:ZDO.+:\SHA.G*/-3DN5=5T_R.O74+(LJ)>699B%55N82S,3@! M5$F22>PKE]G-?8:2\FK%72V:T+>XTAAN-`!N^E`%3^T;`!_",=XNO^ M);59"B:GXGETW_2+@S(%D:T,B6=JC`2;V5YF_:,GX'7Q-6M/V=*\87TC'1OS=M?ELCQ'3_V??%1^ MU0VV@^(O'/B"REDBU#PS\*]&N?%D6C7:$^9:^*/&]A;7&B6%^C<266GRZK<( M6VRF%^*]6>-KH M@;4/#%O<2!9M7\/7/E"5UAWM)-I\S M213('$0BE96/SG$'#&&S2G4KX9?5ZT.K"X MJ6&:B_X/5=8WZK_+J?:G[:WPZ\-^%OA-\5?B)X"M+31?#'Q(/P4O)$T)HK31 MM=UZUU[7[B3Q+:6EDR1P33:'?Z1%),L:?:-P<[F5F;Y;A7&UZN8Y=@<5)SKX M#Z]%>TNYTZ;ITU[)MZV52,VE=\NVS5NS%TXTZ56I37+"?LWIHF[O6R\FO4_+ M7X`SW'_"\_@ZOVFYV_\`"S?!0*FYG*X/B"PR"IDP1[&OT#.8I91F?+%>[A:_ M1+_EW(\W#JU:CT]^/YH_JI/4_6OYZ/I0H`BG_P!1/C_GC+C'_7-J:W7J@>VA M_))J6B^*QJ.I;=%\68_M"^(QI>O8P;J8@C%OT/M7]'TZN'C"G'VM&/+&/VZ: MZ+S/EW&2;]V4>5OHS^EG]DR*XM_V;?@S%=17%O<1^!]+6:*[CEAN8W!ERLT< MZB1']0X!K\)XC<5GF:=FFK=-K:?&O#NEINN;^_EV!I&!,5I:0 M(#+?7TI!$=M`DDLAR%4X..G!X+$XVO#"X.C*M6GM&*V75M[1BNLFTEU9$YPH MQ;E)1BNKT/S/^(WQ-^)/[3_A#Q+KUQ>W'[//['FEV[R>(O&VNZ?YOCCXE:6+ MJ*W6UT72@DC0V-Y8'`8#AS$T*$(+..)JCM2H4Y6 MH86=F[SGI>45=MO5)72@O>//G4J5X2=_JV$CO)KWIKR7GT[^>Q^=?C?XXZ+9 MZ==?#KX$^'[KX5_"NYD2TUS4TF67XH?$2S5D2>Z\:>*8R+B*SEC#R)H=C+#9 MH7VR"3`5/ML)E%7GCC,VK+'9A%7IPM;"X:6Z5"D_=YD]'5FG-[JV[X)58I>S MH1]A2ZO['.9_-Q-YS2&;]Z6K\/S#ZXL;B?KZFL7SR=15+J7-=WWZ?RVTM:VEC MWJ2IQIP5&RIV7+;:WR_$H_>&OB_\/O$G@7Q+IMK>V^K:;=IIL\\49N-& MUD02'2]7TZ=ANM+VVO/*D61&7(#(^Z.1U:\KS"OE.-H8O#3=-T9)R2=E.%_? MA)=8R5TT_5:I,*M*,Z']1Q/_/JW_;T?\S[C^/WASQQX._X M)S>%/"GQ%TY])\6^&]4\(Z+J%C)?6>HM!:Z?XHNX-(4W>GW$\$@_L=;$`1RM MM`"G!!`^2R6OA*W&^(Q&!GS86O&M.,E%PUE23G[LE%KWW+=:[G97C.&`C":Y M90<4UII[VFVFQ^7GP`!_X7K\&PHY_P"%G>"0`.#D^(;#`%?H&=A_XU'I[\?S1^UOQQ_X*&?"CX2ZY?\`A'PSI6H_$OQ-I,\MIJRZ->VN MF>'-*O(F*364^O3QS_;+V&0%98[.VG1&!1Y5=65?RK*>"LQQU&&(KSCEV'DD MX<\7*K*+U4E35N6+Z.4HM[I-:GKUL=2HR<()RE'>SLH_/_)'B'AO_@JOH$M[ M%#XN^#VLZ5I[2*LM]X=\3V6M7%M$3\TG]FW^G:=]H(7G:MPI/09S7KU_#NM& M#>%S.$II:1J4I4DWVYHRG;_P$QCF4;V=%I=T]OE9?F?IC\.OB7X+^*O@[3_' M7@/68=;\/:A'*4FB5X+FTNK<#[7INHV`?B7NMIYH&*V_AH*6AD:-BN=?!VDJ2,@=:^QCX?YG:-L9A4FD]ZJW5 M_P#GV<3S*C%M>SG[OI_F>P_$+]M[X=_#GX??"CXB:KX4\9W>E?%O3+_5=#LM M/AT8ZAID-@ED\L>JK<:K%$DK"^BV^1),/E;)'&[S,%PGC<9C14C6. M*1F<8&9SCA3'9+AZ5>K6I555JQHQA2Y^?GE&4EHX1O\`#:RUNUH%#%TZLG&, M94^5.3;LE96\_,\3^*7_``4X^&7A/5KK1/ASX3U;XD&RED@FU]M0B\->&Y9H MV*M_9DTUI=7FI6^0<3BU@C;[T;2(0S>KE_`./Q%.-7&UX8#F5U3Y74JI/7WD MI1C!^7,VNJ3T,JF8TX-QI0"=/ MU>PU6_U"UO\`5H9[/1H-(U*_T^YGN-6FAM8Q;;;%YS))'$$5\-]W)^8S3*IY M9F=?+*UFUOIV/D3 MXE_\%,_@]X0U"XTGP'X>U_XF36DDD,FJV5:+_P5:T[[6J>(O@MJ-I8,X#3Z'XPM+^[AC)Y?[)?Z/91S,!G MY1<1Y]:]&KX=SC&U#-(\RZ3HN*OZQG)K_P`!9E',DG;V+2\I;?)I'Z'_``7_ M`&@?A;\>=&FU3X=Z^+NXL%C.L>'M0A.G>)-#:4D1_P!HZ5*Q80LPPMS`T]NY MR$E8@@?$YIDN/R:JJ6,H\D97Y*D7S4I]^62Z]XM*2ZH[Z-:E47[N5FMX[->J M_78]L7K7EFPE`'B7QV^/?@3]GOP9/XM\973/<2F2V\.^&K)XCK7B75`FY++3 MX7/[N!25:XO''E6\;;FW.T<);"7:UQ-+$(G%O<*9KD;7N]D.RS'TV/S?!\/T*F4<..U M;X<5C]/:3DMX4I+9)W]Z/NQVA>5YG+2H3K25;$^[%:PI;)+NU_5^O8^[/B'\ M.]!^(GP[\3_#75(4L]"\2:!<:#MM(8XAIB&$+I]S90)M2-[&YBMIX4&U0;9! MP*^1P6-K8#&X?'4G^\P]15-7\6OO*3W]]-J3WU9VSIQE3=+X8M6TZ=K>G0_F M1^,WP.^(?P$\4W/AGQWHT]I$)Y5T7Q);PRMX=\2V:M^YOM)U#;Y9=XRC26DC M)<0,Q22,$`O^]97FV"S;#QKX*JKV7/2;2J46]XSCOOM)>[):IGSM6A4PTN64 M>7L^C]'^FZ.7\%?$CXA?#:[-[X`\;>)_!MPS;I?[!U>ZL;:X)Y/VK3U]=&*R_!8R/)C,)2KQCLJD$VO27Q1^31$)SHO\`=SE3]';\-C[.\#?\ M%)OVA?"WDV_B6/PE\0+*,*C'6-*.AZMY:]<:EH#00M+C^.6QE)/)S7RV+X$R M6M?ZO[;`R[0GSP_\`J7=O)31V0S"O#W7RM>:L_O5OR/T*^!W_!0GX1?%34;' MPQXIM;OX6^*[Z6*UL8-=NX+OPUJ5Y*51+:R\21)"EM<22MA(K^"TW%E5'=R` M?B\VX*S++(3K862QN&I)N3IQ<:L([WE2=VTENX.5MVDCNH8VE)J$E[*72^VO M9_YI%W_@H[Q^S!KH^[M\6^#,=L9U=:G@?_D?T?\`KS7_`/2!X_3#2_Q1_,_G MQTVYU&QU"QNM&FN[;5;>Z@?39K!WBOH+[S%%LUF\1#I=><4V%"&#$8YZ_L\X M0Y)1FE[.SYE+X>6VO,GI:V]^AX:337+[K6UM+,_6_P"'?_!+2._\+Z?J7Q*^ M)&L:'XFO[2*[N=!\,:7ITMKH6VBN>HXR[12T M^;W?<^"OVE?V>-=_9M\?IX0U'4X]>T?5=.&M>%_$,5M]A;4M,^T26LT5Y9"6 M5;/4[6XC*31I(Z$212(=LH5?L,@SFCG6#^L4J?U>K1ER5:=[\DK73B[*\9)W M3LGNGL<6(P\L)4Y+W5KQ>VGIT9]?_P#!+[QQ?:=X^^(OPZ>YD_L?Q!X1;Q3; M6;,3%#K6@7EK82SPH3A);C3=5*R%0-XL(=Q_=K7S7'^$A]3P6-45&K0K>R;V M?)4BY)/RC*&G;F?=G5ELW&=2G\,>7F2VU3_R?X'YBZG_`,A+4_\`L(W_`/Z5 M35][3^"G_AC^2//>[]6?>G[47_)KW[$__8G^)O\`T3X>KX_A_P#Y'_%7_7ZE M^=0[<1_N^$_PO]#XAT+Q+K^@6OB+2]`N[BS3QEHR>%]9CLQ(MSJ&D3:MIFJO MI2&+YS'=7VEV*21J#YJ!HB"LA!^KK4*-25"52*?U6?M87M:$U"4.?72\8SDT M^CUZ:\492IJ2B^7F7*[=KIV^;1]Q^`?^";/Q\\7Z%:ZYK%_X0^'@O(8[BUT7 MQ)<:G_W+8Y;]H_QMXN^&7@7P;^QY'KM MA<6'PTMKFX^(=_X:/?-I1U&SM M(KG6==U:.**>YL=(CN?]'MK:VBG@\^\F64!YUCCB=ED,1Q'Q12R%T\/2HK$8 MVI'GY9-QA3@VTI3MJW)I\L5;17;6ES"X-UKRYO9TXNUUNWV71>;/K3XI_P#! M+S0;'PIJ.I_"3QMXFNO%&EV4UW;:!XL&EW=EK\EO$TK6%M?:=8V:,J=W;F<92DI16\DK.VJN]' MTU,MC"#]C-IQ^S*UO2Z2L?EI\+OB3XM^"WC_`$3QWX5GGT_6O#U[MO+!VDAA MU2P$H35?#^K0*1YMI-="!/"TC12#L\3CM7\^XO"U,#B:^#JQY*F&J2IR7G M%M77D]UY,^EA).$915E))KYG/_%GXH>%_@SX!\0?$'Q=<&'2=!M=Z6L3(+S5 M-1G/E:;HVG(Q`DOKRZ9(D'10S2.1'&[+MEN78C,L91P6$C:I4>[TC"*UE.7: M,5=OOLM6B:E2-"G*4M%#Y:O9+S9^;7[+WP\\3_M7?$S4/VJOCC`MWX(O&/A#P=':2^*_%7ASPK%>O+'8R>(=;TW18[N2)5>:.U;4;F$7# MQJZ%EC+%0ZDXW"MJ&%Q.)_K-/#8O!.CK[54ZM+DN^L[1Y4WYV9'-0?N*4)?W;Q?X M'S-X\_X)T?LW^+FGN-#T?7?AU?N&*2>$-8E33EE;G>=%UA+VU1,_\LX%MU[# M%>_@N-L\P=HU*E/%PCTK07-;_'#DE\WS'/+`8?[,72?]UV7W.Z/A[XI_\$P_ MB/X7L[O5OAAXOTSX@VUI&\R^']4L_P#A&_$TR(K.T=C*MQ/IU_<;1@(\EB7. M`H).*^KR[CW`U91I8[#2P+;M[2$O:4E?^96C.*\TIVZG%4RVI!/V4E)+H_=? MRZ?D?F;>6=UI]U=:=J%K/8WME<3V=[97<+V]U:7=M*T-S:W,$@#PW$4R.CHP M#*R$'D5][%Q<8RI23A)*491=TTU=--:--.Z?4\]IJ\;-:,\-!4:.,PU:LHI649VE&HHI:).2YK=.9I:'H.HW@&F[ M2ISC'MINO\OD?$?P,L[>]^-7PCLKN-9+6X^)/@J*>%@"LD;>(=/+(P(QM..1 MWKZS-G*EE69.#Y90PM=I[6?LY''0BO;4ELN>/YH_JW/4_6OYW/IC\ M3F>CH?\`;W_MIX%_P39^7]HF\[;?AMXM]L9N=%KV..=,DCTMB:/Y3,[]6?>G[47_)KW[$__`&)_ MB;_T3X>KX_A__D?\5?\`7ZE^=0[<1_N^$_PO]#S[]A'PAIGC#]IWP!:ZM#'/ M9Z!'K?BY;:5`T+L34P>08QTGR2K.%&Z MT:C4DE/[XJ4?F9X&"^L4U\*C>5O-+3\=3^DL=?Q']*_##Z`_E)^.>IW6K?&K MXMZG>2%[J[^(_C)Y&))VB/7[Z&*-2>B1PQ1QJ.RHH[5_1&44XT,JRVG! M&H6Z;TXMOU;;;\SYFJVJU6WNVG+\V=_\.?VL_P!H#X3^$[#P3X`\76^A^&=- MFO;BTL?^$2\.ZBPGU&ZEO;N62]OM*FGN'>XF1MHVH,*`!Q8WAS)L?B)XK M&89SKR44Y>VJ1TBE&*48S25DNBUW^T73Q-:A!0IRY8QV7*NNKZ'[3H1C"*B6KU?4Y&W=RV;=WTU?ET/Z./V"KF6Y_9 M/^$[2F3S+>'QC9CS592L-G\0/%=M;(`P!\M+:.)%[80`=*_#^+XJGQ%F,8I1 M3=&6G>6'I-_>VW\SZ#`Z86E]FW-Y?:ET/@#_`(*;_$C5-=^)7@SX-:?)YI[.PEG&=KI9:5&OE%A\IU2X/?G[/@'`4\/@,5F;C^ M\KSE3B^L*5)*4DNW/-Z]^1?/@S&;]I"C'14TF^FLMON7YL_8GX=>"]*^'7@/ MPCX&T.&.VTWPKX?TS1[=8UV!VM;:-;BZ<=YKFZ\ZXD8\M).['EJ_,<;B:F,Q MF)Q55VG7J3F_+F>B\DE9+R2/6IP5*G"G'W5!)?UZG:5S%GYM_P#!3?X?7OB; MX*>'_&%A:FY_X5UXJ6^U1$BWM;Z'K]JVDW5Z>"5BAU`:5O/0)(SGA#7W/`6, MAA M?"WXA>#?B#I%I#/?^#O$%AK<5H^(DO8K>7%[8/(JYB6ZLGN("X'R^=N[5^JX M_"1QN"Q6!J2<88FG*%U]EM:22_NRM*W6QX]*7L:D)15G!IV_-?-']+GPJ_:3 M^#7Q?T.SU;PIXVT.&\DAB>^\-:OJ-GI'B31[F109+.^TJ[G25FCSM)=4CZ&E7HSBN2:3_E M;2:^7](Z?QM\:?A/\.-)N=9\8?$#PKHEG;1&7RY-9LIK^X(!*PV&EVDLEW?W M#D86."&1B6Z5AA,JS'&5(T<)@JLY7MI"2C'SE)I1BO-M%3JTJ*]Z<8)>:O\` M);G\RGQH\;V'Q*^+/Q#\?:38R:7IGBSQ5JFLZ?9SJD=S%97$VVV>Z2,E4O)H MHTFF4$@23.,MC+?O.582>7Y;@L%4FI5,+1A"36W,EK:_V4W9>21\]5FG5J22 MY4Y-I;:=#ZC\/>#=0T'_`()\_$;Q7>0R6T'C?XP>$9=)$B-'Y^F>'[FWTLWD M8/#0OJ1U*)6'4VK'IC/S];$PEQG@<+3:3P>#K*=OL3J)SY?7EY7_`-O'3&#A M@:DE[JE4C;T6GYW/FK]G_P#Y+G\'/^RF^"?_`%(+"O=SG_D49G_V"U__`$W( MY\/_`!Z/^./YH_JN/4_6OYY/I3\=O^"KG^M^!O\`N?$'_P!"\(5^F^'>V;?] MP/\`W,>3F7_+C_M__P!M/GW_`()L_P#)Q%Y_V3;Q=_Z4Z-7L\KX_A_\`Y'_%7_7ZE^=0[<1_N^$_PO\`0S/^"Z?S+?MD_# MV]^''[1GQ)TZ:W>WT_Q'K4_C?0I=C+#<:7XIEDU)S`Q`#+;ZH^HVC`=&M"/2 MOWGA?&PQF28&<7[^'@J%1=5.DN77_%#EEYJ1\[BJ;HXBHDN5-\R]):_G='Z0 M_P#!-SXM>"-:^&C_``@UB?1K7QIX5U?5;S1[#44LX[G7?#VLW+:DLVF&&,L\<;6[XV/\OPW'.68O#X]9E0C/ZK7A",Y1O:G4@N6TK?"I147 M%O1OF6Z/0R^I#V?L=(SIMV3[/73T=[GZ0:]<>#O"NDWNN^(W\.Z#HNFPO<7V MJ:JNG6-C:PQJ69Y;BX5$3@'`SEC@*"2!7PU&.*K5(4:"J5*LG:,((-"L-0N[;2M>?7M-TDZQ8 MV\K1PZFNFS>')9+&.X5?-2*21G".N[#9`_0:'`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`JFVL7.">.2!55<5AL-%NIBJ5"$-??JPBE]\D M$83O:$)7\D_T1]Y_`3_@G;\4O'>J6.K?%BSN?AEX(AE2:[L+F2`^-=9A5MS6 M-GILRAV^T_*W3U?W'Z'?MH?"Z_G_98/PX^%'@O4-271=6 M\%6>B>%O"^G37US;Z3I-^@8PVL`:21(H5WRRMN8EF=V+,2?BN%LPA3XA^NYA MBHTO:0KRG5JR44YSB]V[)7>R^2.[%TG]6]E2@_=<4HQ71>1^37P2_9Y^/&B_ M&3X5:MJOP<^(^EZ5I7Q"\(W^HZA>^%M2MK/3[&UURRFNKNZG>(+#;Q0H[N[$ M!54D]*_1LUSK)YY7F-*EF>&E4J8:M&,8U8MRE*G)))7U;;LEU/,H8>M3K4OW M,X*,XMOE:LKH_I-/4_6OPP^@/RM_X*5_#+XB_$&7X.GP!X&\4>,1HZ>.!J9\ M-Z/=:H-.-\?"_P!D%Y]E1O(\[[-<;-V-WDOC[IK]"X$Q^!R]9G];Q=+!\_L. M3VLU#FM[7FY;VO:ZOWNCS,PI3?L?9PD^7FORK:_*>(?L!_!CXN>`_CM=:UXR M^&?C;PIH[>`/$]BNIZ]H%]IEBU[YE964B'E64@@]P?S^IAGN2J$(_VK MA8\L8Z>VAV5^IR/#8A-_N9Q_[=9]H_M%?!GXN:[^SI^R-X>T'X9^-M6USPIX M6\06WB72-.T"^N-1T"YN(M#$,&K6L49>RED,,P59`"?*;'2OELCS3+S2NKV[G77HU/J^%C&G*\(NZ2=X[;F=^P7\% M?B_X&_:)T?7_`!C\,?''A70X?"GBRUEU?7?#U]ING17-U:6Z6T#W,\:HLLK* MP166 MK32U/W1K\D/9/E7]JC]ESPY^TCX3M;5KN+P[XY\.BXE\)>*3;F:.'[0`USHV ML0QXDN=#NI$B9@A\R"1%FAR=\)O(L9BU MIXF\*V=YX@T27;S'=6>K:)%(]HQ7Y@MPEK,N2&12#7Z]@<_R?'TTZ&-I)R6M M*JU2FK[IPFTGZQ+/#5J#UIN*CLX[?>MOP.&&@?&'QI-:Z.VB_%;Q9,' M46>FW6G^,]<$;\*A@MKN*9(CT`8!<>M=GMLLP2E-5<)A%UE&5"GZW<6F1RU= M(\L_)6D_P/T3_92_X)]^++SQ%HWC_P".VE+X>\.:-<0:IIG@"Z>&;6M>OK>0 M2V?_``D<,+O'I.CQS*LDEF[M<7!C$4B11,WF?$\1<98:E0JX+)ZGMJ]1.$L1 M&\84XO27LF[._YT`&T>_YT`&T>_YT`&T>_P"=`"%%(*D# M;_=8`C\B*%[NWNV[:!Z:"+&D:A8U$:CHJ`(HSUP%`Q0`[:/?\Z`%Q[F@`Q[F M@!-H]_SH`7&/4?I0`8]S0`8]S0`8QQD\?AUH`,>YH`3:/?\`.@`VCW_.@!<> 5YH`,8[G^5`";1[_G0`H&W_.*`/_9 ` end EX-99.2 4 dp10820_ex9902.htm
 
EXHIBIT 99.02
 
Hampshire International Business Park
Chineham  Basingstoke
Hampshire RG24 8EP
United Kingdom
Tel +44 (0)1256 894000
Fax +44 (0)1256 894708
www.shire.com
   
Press Release
  
 

Notification of major interests in shares
 
Basingstoke, UK and Philadelphia, US – July 30, 2008 – Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Shire Limited

2. Reason for the notification
State
Yes/No
An acquisition or disposal of voting rights
Yes
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
  
An event changing the breakdown of voting rights
  
Other (please specify):  New Exemption DTR 5.1.3 (4) & DTR 5.1.5 (1)
Yes

3. Full name of person(s) subject to the notification obligation:
The Goldman Sachs Group Inc
4. Full name of shareholder(s) (if different from 3.):
Goldman, Sachs & Co.,
Goldman Sachs Financial Markets, L.L.C.
Spear, Leeds & Kellogg Specialists, L.L.C.
5. Date of the transaction (and date on which the threshold is crossed
or reached if different):
28 July 2008
6. Date on which issuer notified:
30 July 2008
7. Threshold(s) that is/are crossed or reached:
Below 3%
8. Notified details:
  

A: Voting rights attached to shares

Class/type of shares
 if possible using the ISIN CODE
Situation previous to
the Triggering
transaction
Resulting situation after the triggering
transaction
 
Number
of
Shares
Number
of
Voting
Rights
Number
of
shares
Number of voting
rights
% of voting
rights
     
Direct
Direct
Indirect
Direct
Indirect
US82481R1068
17,252,839 (5,750,953 ADRs)
3.08%
          
 
 

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 
 
 
 
B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument
Expiration
date
Exercise/Conversion
Period/ Date
Number of voting
rights that may be
acquired if  the instrument
is exercised/converted
% of voting
rights
         


Total (A+B)
  
Number of voting rights
% of voting rights
 
Below 3%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

We hereby notify you that as at close of business on 28 July 2008, The Goldman Sachs Group, Inc., of 85 Broad Street, New York, NY 10004, USA, no longer has a notifiable interest in shares.

Proxy Voting:

10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A

13. Additional information:
General Email Contact: shareholderdisclosures@gs.com
14. Contact name:
Sean Rogers/Alan Cox
15. Contact telephone number:
0207-552-9205 / 0207-774 -8774

Contact at Shire Limited: Tony Guthrie, Deputy Company Secretary, 01256 894746
 

 
For further information please contact:

Investor Relations
Cléa Rosenfeld (Rest of the World)
+44 1256 894 160
 
Eric Rojas (North America)
+1 484 595 8252


Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 
 

Notes to editors

SHIRE LIMITED

Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions.  Shire’s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.  Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company’s website: www.shire.com.
 
 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

 
 -----END PRIVACY-ENHANCED MESSAGE-----